Skip to main content

Table 1 Key indicators for disease prevalence and treatment for pneumonia and diarrhoea

From: Impact of an integrated community case management programme on uptake of appropriate diarrhoea and pneumonia treatments in Uganda: A propensity score matching and equity analysis study

Disease/treatment 2009   2012   Increase year on year percentage points p-value
  N (1178) % N (1476) %   
Two week prevalence of ‘fast-breathing’ pneumonia 263 22.3 % 453 30.7 % 8.4 0.000a
Two week prevalence of diarrhoea 168 14.6 % 229 15.6 % 1.0 0.470
‘Fast-breathing’ pneumonia treated with appropriate antibiotics 147 55.9 % 301 66.4 % 10.5 0.000a
Diarrhoea treated with ORS 58 34.5 % 117 51.1 % 16.6 0.001a
Diarrhoea treated with ORS plus zinc 5 3.0 % 27 11.8 % 8.8 0.001a
Treatment First source of care 2012 p-value
   iCCM n (%) Other n (%)  
‘Fast-breathing’ pneumonia treated with appropriate antibiotics (N = 453)   184 (85.6) 117 (49.2) 0.000a
Diarrhoea treated with ORS (N = 229)   65 (80.2) 52 (35.14) 0.000a
Diarrhoea treated with ORS plus zinc (N = 229)   22 (14.9) 5 (6.2) 0.056
  1. aSignificant at 95 % level of significant